Literature DB >> 29434965

Expression of CXC-motif-chemokine 12 and the receptor C-X-C receptor 4 in glioma and theeffect on peritumoral brain edema.

Wenlong Tang1, Yupeng Chen2, Xingfu Wang2, Yao Chen1, Jiandong Zhang1, Zhixiong Lin1,3.   

Abstract

The present study aimed to evaluate the association between CXC-motif-chemokine 12 (CXCL12)/C-X-C receptor 4 (CXCR4) expression and peritumoral brain edema (PTBE) in glioma patients. Immunohistochemical techniques were used to detect the expression of CXCR4 and CXCL12 in 58 glioma tissues. Magnetic resonance imaging was used to evaluate the extent and type of brain edema in preoperative glioma patients. The association between edema and CXCL12/CXCR4 expression was examined by χ2 analysis. The prognostic significance of CXCL12 or CXCR4 was determined by log-rank tests and Cox's proportional hazards model. Expression of CXCL12 and CXCR4 was observed in vascular endothelial cells and tumor cells. The degree (P=0.033) and morphology (P=0.033) of PTBE were significantly associated with the level of CXCL12 expression in vascular endothelial cells. The degree (P=0.001) and morphology (P=0.001) of PTBE were associated with the level of CXCR4 expression in tumor cells. CXCR4-positive vascular endothelial cells were significantly associated only with the degree of edema (P=0.030). Therefore, the present study indicated that levels of CXCL12 expression in vascular endothelial cells and CXCR4 expression in tumor cells are associated with PTBE.

Entities:  

Keywords:  C-X-C receptor 4; CXC-motif-chemokine 12; glioma; peritumoral brain edema

Year:  2017        PMID: 29434965      PMCID: PMC5777335          DOI: 10.3892/ol.2017.7547

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.

Authors:  Xin Hong; Feng Jiang; Steven N Kalkanis; Zheng Gang Zhang; Xue-Peng Zhang; Ana C DeCarvalho; Mark Katakowski; Kevin Bobbitt; Tom Mikkelsen; Michael Chopp
Journal:  Cancer Lett       Date:  2005-06-20       Impact factor: 8.679

3.  CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.

Authors:  Yan Zhou; Peter H Larsen; Chunhai Hao; V Wee Yong
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

4.  Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt.

Authors:  Simone Barbero; Rudy Bonavia; Adriana Bajetto; Carola Porcile; Paolo Pirani; Jean Louis Ravetti; Gian Luigi Zona; Renato Spaziante; Tullio Florio; Gennaro Schettini
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

5.  CXCR4 expression mediates glioma cell invasiveness.

Authors:  M Ehtesham; J A Winston; P Kabos; R C Thompson
Journal:  Oncogene       Date:  2006-05-04       Impact factor: 9.867

6.  CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities.

Authors:  Charles B Stevenson; Moneeb Ehtesham; Kathryn M McMillan; J Gerardo Valadez; Michael L Edgeworth; Ronald R Price; Ty W Abel; Khubaib Y Mapara; Reid C Thompson
Journal:  Neurosurgery       Date:  2008-09       Impact factor: 4.654

7.  SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia.

Authors:  Dah-Yuu Lu; Chih-Hsin Tang; Wei-Lan Yeh; Kar-Lok Wong; Chih-Peng Lin; Yi-Hung Chen; Chih-Ho Lai; Yuh-Fung Chen; Yuk-Man Leung; Wen-Mei Fu
Journal:  Eur J Pharmacol       Date:  2009-03-11       Impact factor: 4.432

8.  Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.

Authors:  Xiu-wu Bian; Shi-xin Yang; Jian-hong Chen; Yi-fang Ping; Xiang-dong Zhou; Qing-liang Wang; Xue-feng Jiang; Wanghua Gong; Hua-liang Xiao; Lin-lin Du; Zi-qiang Chen; Wen Zhao; Jing-quan Shi; Ji Ming Wang
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654

9.  Cellular characterization of the peritumoral edema zone in malignant brain tumors.

Authors:  Tobias Engelhorn; Nic E Savaskan; Marc A Schwarz; Jürgen Kreutzer; Eric P Meyer; Eric Hahnen; Oliver Ganslandt; Arnd Dörfler; Christopher Nimsky; Michael Buchfelder; Ilker Y Eyüpoglu
Journal:  Cancer Sci       Date:  2009-07-24       Impact factor: 6.716

10.  The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract.

Authors:  K Tachibana; S Hirota; H Iizasa; H Yoshida; K Kawabata; Y Kataoka; Y Kitamura; K Matsushima; N Yoshida; S Nishikawa; T Kishimoto; T Nagasawa
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  1 in total

1.  Inflammation and behavioral symptoms in preoperational glioma patients: Is depression, anxiety, and cognitive impairment related to markers of systemic inflammation?

Authors:  Li Song; Xingyun Quan; Lin Su; Ke Wang; Haorun Wang; Lihong Wu; Chaoyi Chen; Shenjie Li; Wei Xiang; Ligang Chen; Jie Zhou
Journal:  Brain Behav       Date:  2020-08-13       Impact factor: 2.708

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.